Eicosanoids are signaling molecules made by the enzymatic or non-enzymatic oxidation of arachidonic acid or other polyunsaturated fatty acids (PUFAs) that are, similar to arachidonic acid , around 20 carbon units in length. Eicosanoids are a sub-category of oxylipins , i.e. oxidized fatty acids of diverse carbon units in length, and are distinguished from other oxylipins by their overwhelming importance as cell signaling molecules. Eicosanoids function in diverse physiological systems and pathological processes such as: mounting or inhibiting inflammation , allergy , fever and other immune responses ; regulating the abortion of pregnancy and normal childbirth ; contributing to the perception of pain ; regulating cell growth ; controlling blood pressure ; and modulating the regional flow of blood to tissues. In performing these roles, eicosanoids most often act as autocrine signaling agents to impact their cells of origin or as paracrine signaling agents to impact cells in the proximity of their cells of origin. Some eicosanoids, such as prostaglandins , may also have endocrine roles as hormones to influence the function of distant cells.
73-430: There are multiple subfamilies of eicosanoids, including most prominently the prostaglandins, thromboxanes , leukotrienes , lipoxins , resolvins , and eoxins . For each subfamily, there is the potential to have at least 4 separate series of metabolites, two series derived from the ω−6 PUFAs arachidonic and dihomo-gamma-linolenic acids, one series derived from the ω−3 PUFA eicosapentaenoic acid, and one series derived from
146-417: A 15-hydroperoxy product, creating a carbon-carbon bond between carbons 8 and 12 to create a cyclopentane ring in the middle of the fatty acid, and in the process making PGG 2 , a product that has two fewer double bonds than arachidonic acid. The 15-hydroperoxy residue of PGG 2 is then reduced to a 15- hydroxyl residue thereby forming PGH 2 . PGH 2 is the parent prostanoid to all other prostanoids. It
219-404: A dehydration reaction to form in series Δ12-PGJ 2 and 15-deoxy-Δ12,14-PGJ 2 . PGH 2 has a 5-carbon ring bridged by molecular oxygen. Its derived PGS have lost this oxygen bridge and contain a single, unsaturated 5-carbon ring with the exception of thromboxane A 2 which possesses a 6-member ring consisting of one oxygen and 5 carbon atoms. The 5-carbon ring of prostacyclin is conjoined to
292-409: A far greater extent than LTB 4 . 5-LOX may also work in series with cytochrome P450 oxygenases or aspirin-treated COX2 to form Resolvins RvE1, RvE2, and 18S-RvE1 (see Specialized pro-resolving mediators § EPA-derived resolvins ). The enzyme arachidonate 12-lipoxygenase (12-LO or ALOX12) metabolizes arachidonic acid to the S stereoisomer of 12-hydroperoxyeicosatetraenoic acid (12-HPETE) which
365-446: A few hours. Paralysis is a very late sign of acute arterial ischemia and signals the death of nerves supplying the extremity. Foot drop may occur as a result of nerve damage . Because nerves are extremely sensitive to hypoxia , limb paralysis or ischemic neuropathy may persist after revascularization and may be permanent. Cardiac ischemia may be asymptomatic or may cause chest pain, known as angina pectoris . It occurs when
438-550: A sampling of the major eicosanoids that possess clinically relevant biological activity, the cellular receptors (see Cell surface receptor ) that they stimulate or, where noted, antagonize to attain this activity, some of the major functions which they regulate (either promote or inhibit) in humans and mouse models, and some of their relevancies to human diseases. Many of the prostanoids are known to mediate local symptoms of inflammation : vasoconstriction or vasodilation , coagulation , pain , and fever . Inhibition of COX-1 and/or
511-716: A second ring consisting of 4 carbon and one oxygen atom. And, the 5 member ring of the cyclopentenone prostaglandins possesses an unsaturated bond in a conjugated system with a carbonyl group that causes these PGs to form bonds with a diverse range of bioactive proteins (for more see the diagrams at Prostanoid ). The enzyme 5-lipoxygenase (5-LO or ALOX5) converts arachidonic acid into 5-hydroperoxyeicosatetraenoic acid (5-HPETE), which may be released and rapidly reduced to 5-hydroxyeicosatetraenoic acid (5-HETE) by ubiquitous cellular glutathione -dependent peroxidases . Alternately, ALOX5 uses its LTA synthase activity to act convert 5-HPETE to leukotriene A 4 (LTA 4 ). LTA 4
584-537: A small study of 32 volunteers EXC 4 production by eosinophils isolated from severe and aspirin-intolerant asthmatics was greater than that from healthy volunteers and mild asthmatic patients; these findings have been suggested to indicate that the eoxins have pro-inflammatory actions and therefore potentially involved in various allergic reactions. Production of eoxins by Reed–Sternberg cells cells has also led to suggestion that they are involved in Hodgkins disease . However,
657-423: A vessel from compression , shearing , or laceration . Acute arterial occlusion may develop as a result of arterial dissection in the carotid artery or aorta or as a result of iatrogenic arterial injury (e.g., after angiography ). An inadequate flow of blood to a part of the body may be caused by any of the following: Ischemia results in tissue damage in a process known as ischemic cascade . The damage
730-703: Is a vascular disease involving an interruption in the arterial blood supply to a tissue , organ , or extremity that, if untreated, can lead to tissue death. It can be caused by embolism , thrombosis of an atherosclerotic artery, or trauma. Venous problems like venous outflow obstruction and low-flow states can cause acute arterial ischemia . An aneurysm is one of the most frequent causes of acute arterial ischemia. Other causes are heart conditions including myocardial infarction , mitral valve disease , chronic atrial fibrillation , cardiomyopathies , and prosthesis , in all of which thrombi are prone to develop. The thrombi may dislodge and may travel anywhere in
803-448: Is a 6-membered ether -containing ring. Thromboxane is named for its role in blood clot formation ( thrombosis ). Thromboxane-A synthase , an enzyme found in platelets , converts the arachidonic acid derivative prostaglandin H 2 to thromboxane. People with asthma tend to have increased thromboxane production, and analogs of thromboxane act as bronchoconstrictors in patients with asthma. Thromboxane acts by binding to any of
SECTION 10
#1733092441323876-455: Is achieved by mediating expression of the glycoprotein complex GP IIb/IIIa in the cell membrane of platelets. Circulating fibrinogen binds these receptors on adjacent platelets, further strengthening the clot . It is believed that the vasoconstriction caused by thromboxanes plays a role in Prinzmetal's angina . Omega-3 fatty acids are metabolized to produce higher levels of TxA 3 , which
949-460: Is adequate. The signs and symptoms of ischemia vary, as they can occur anywhere in the body and depend on the degree to which blood flow is interrupted. For example, clinical manifestations of acute limb ischemia (which can be summarized as the "six P's" ) include pain , pallor , pulseless , paresthesia , paralysis , and poikilothermia . Without immediate intervention, ischemia may progress quickly to tissue necrosis and gangrene within
1022-484: Is also a potent pyretic agent. Aspirin and NSAIDS—drugs that block the COX pathways and stop prostanoid synthesis—limit fever or the heat of localized inflammation. In 1930, gynecologist Raphael Kurzrok and pharmacologist Charles Leib characterized prostaglandin as a component of semen. Between 1929 and 1932, George and Mildred Burr showed that restricting fat from animals' diets led to a deficiency disease, and first described
1095-417: Is also in clinical development studies for the treatment of neurodegenerative diseases and hearing loss. The metabolites of eicosapentaenoic acid that are analogs of their arachidonic acid-derived prostanoid, HETE, and LT counterparts include: the 3-series prostanoids (e.g. PGE 3 , PGD 3 , PGF 3α , PGI 3 , and TXA 3 ), the hydroxyeicosapentaenoic acids (e.g. 5-HEPE, 12-HEPE, 15-HEPE, and 20-HEPE), and
1168-399: Is essential to keep the affected organ viable. The treatment options include injection of an anticoagulant , thrombolysis , embolectomy , surgical revascularization, or partial amputation. Anticoagulant therapy is initiated to prevent further enlargement of the thrombus . Continuous IV unfractionated heparin has been the traditional agent of choice. If the condition of the ischemic limb
1241-561: Is given the trivial names of 5 S -HETE, 5( S )-HETE, 5S-HETE, or 5(S)-HETE). Since eicosanoid-forming enzymes commonly make S isomer products either with marked preference or essentially exclusively, the use of S / R designations has often been dropped (e.g. 5 S -HETE is 5-HETE). Nonetheless, certain eicosanoid-forming pathways do form R isomers and their S versus R isomeric products can exhibit dramatically different biological activities. Failing to specify S / R isomers can be misleading. Here, all hydroperoxy and hydroxy substituents have
1314-958: Is metabolized by (see diagram in Prostanoid ): a) The prostaglandin E synthase pathway in which any one of three isozymes , PTGES , PTGES2 , or PTGES3 , convert PGH 2 to PGE 2 (subsequent products of this pathway include PGA 2 and PGB 2 (see Prostanoid § Biosynthesis of prostaglandins ); b) PGF synthase which converts PGH 2 to PGF 2α ; c) Prostaglandin D 2 synthase which converts PGH 2 to PGD 2 (subsequent products in this pathway include 15-dPGJ 2 (see Cyclopentenone prostaglandin ); d) Thromboxane synthase which converts PGH 2 to TXA 2 (subsequent products in this pathway include TXB 2 ); and e) Prostacyclin synthase which converts PGH 2 to PGI 2 (subsequent products in this pathway include 6-keto-PGFα. These pathways have been shown or in some cases presumed to metabolize eicosapentaenoic acid to eicosanoid analogs of
1387-482: Is pathogenic in various diseases, such as ischemia-reperfusion injury., hepatic inflammatory processes, acute hepatotoxicity etc. TxB2, a stable degradation product of TxA2, plays a role in acute hepatoxicity induced by acetaminophen. Thromboxane inhibitors are broadly classified as either those that inhibit the synthesis of thromboxane, or those that inhibit the target effect of it. Thromboxane synthesis inhibitors, in turn, can be classified regarding which step in
1460-435: Is rapidly reduced by cellular peroxidases to the S stereoisomer of 12-hydroxyeicosatetraenoic acid (12-HETE) or further metabolized to hepoxilins (Hx) such as HxA3 and HxB. The enzymes 15-lipoxygenase -1 (15-LO-1 or ALOX15 ) and 15-lipoxygenase-2 (15-LO-2, ALOX15B ) metabolize arachidonic acid to the S stereoisomer of 15-hydroperoxyeicosatetraenoic acid (15(S)-HPETE) which is rapidly reduced by cellular peroxidases to
1533-451: Is relatively less potent than TxA 2 and PGI 3 ; therefore, there is a balance shift toward inhibition of vasoconstriction and platelet aggregation. It is believed that this shift in balance lowers the incidence of myocardial infarction (heart attack) and stroke. Vasoconstriction and, perhaps, various proinflammatory effects exerted by TxA on tissue microvasculature, is probable reason why the TxA
SECTION 20
#17330924413231606-464: Is stabilized with anticoagulation , recently formed emboli may be treated with catheter-directed thrombolysis using intra-arterial infusion of a thrombolytic agent (e.g., recombinant tissue plasminogen activator ( tPA ), streptokinase , or urokinase ). A percutaneous catheter inserted into the femoral artery and threaded to the site of the clot is used to infuse the drug. Unlike anticoagulants , thrombolytic agents work directly to resolve
1679-437: Is the result of the build-up of metabolic waste products, inability to maintain cell membranes , mitochondrial damage, and eventual leakage of autolyzing proteolytic enzymes into the cell and surrounding tissues. Restoration of blood supply to ischemic tissues can cause additional damage known as reperfusion injury that can be more damaging than the initial ischemia. Reintroduction of blood flow brings oxygen back to
1752-425: Is then metabolized either to LTB 4 by leukotriene A 4 hydrolase or leukotriene C 4 (LTC 4 ) by either LTC 4 synthase or microsomal glutathione S-transferase 2 ( MGST2 ). Either of the latter two enzymes act to attach the sulfur of cysteine's thio- (i.e. SH) group in the tripeptide glutamate - cysteine - glycine to carbon 6 of LTA 4 thereby forming LTC 4 . After release from its parent cell,
1825-633: The National Library of Medicine state that there is 'A' level evidence that increased dietary ω−3 improves outcomes in hypertriglyceridemia , secondary cardiovascular disease prevention, and hypertension . There is 'B' level evidence ('good scientific evidence') for increased dietary ω−3 in primary prevention of cardiovascular disease, rheumatoid arthritis , and protection from ciclosporin toxicity in organ transplant patients. They also note more preliminary evidence showing that dietary ω−3 can ease symptoms in several psychiatric disorders. Besides
1898-457: The Nobel Prize in medicine in 1970, which Samuelsson, Vane, and Bergström also received in 1982. E. J. Corey received it in chemistry in 1990 largely for his synthesis of prostaglandins. Thromboxane Thromboxane is a member of the family of lipids known as eicosanoids . The two major thromboxanes are thromboxane A2 and thromboxane B2 . The distinguishing feature of thromboxanes
1971-521: The S configuration unless noted otherwise. Current usage limits the term eicosanoid to: Hydroxyeicosatetraenoic acids, leukotrienes, eoxins and prostanoids are sometimes termed "classic eicosanoids". In contrast to the classic eicosanoids, several other classes of PUFA metabolites have been termed 'novel', 'eicosanoid-like' or ' nonclassic eicosanoids '. These included the following classes: Metabolism of eicosapentaenoic acid to HEPEs, leukotrienes, prostanoids, and epoxyeicosatetraenoic acids as well as
2044-800: The S stereoisomer of 15-hydroxyeicosatetraenoic acid (15(S)-HETE). The 15-lipoxygenases (particularly ALOX15) may also act in series with 5-lipoxygenase, 12-lipoxygenase, or aspirin-treated COX2 to form the lipoxins and epi-lipoxins or with P450 oxygenases or aspirin-treated COX2 to form Resolvin E3 (see Specialized pro-resolving mediators § EPA-derived resolvins ). A subset of cytochrome P450 (CYP450) microsome -bound ω hydroxylases metabolize arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE) and 19-hydroxyeicosatetraenoic acid by an omega oxidation reaction. The human cytochrome P450 (CYP) epoxygenases, CYP1A1, CYP1A2, CYP2C8, CYP2C9, CYP2C18, CYP2C19, CYP2E1, CYP2J2, and CYP2S1 metabolize arachidonic acid to
2117-501: The SN2 position of membrane phospholipids ; PLA 2 act as esterases to release the fatty acid. There are several classes of PLA 2 with type IV cytosolic PLA 2 (cPLA 2 ) appearing to be responsible for releasing the fatty acids under many conditions of cell activation. The cPLA 2 act specifically on phospholipids that contain AA, EPA or GPLA at their SN2 position. cPLA 2 may also release
2190-784: The cell membrane and nuclear membrane . These fatty acids must be released from their membrane sites and then metabolized initially to products which most often are further metabolized through various pathways to make the large array of products we recognize as bioactive eicosanoids. Eicosanoid biosynthesis begins when a cell is activated by mechanical trauma, ischemia , other physical perturbations, attack by pathogens , or stimuli made by nearby cells, tissues, or pathogens such as chemotactic factors , cytokines , growth factors , and even certain eicosanoids. The activated cells then mobilize enzymes, termed phospholipases A 2 (PLA 2 ), capable of releasing ω−6 and ω−3 fatty acids from membrane storage. These fatty acids are bound in ester linkage to
2263-481: The circulatory system , where they may lead to pulmonary embolus , an acute arterial occlusion causing the oxygen and blood supply distal to the embolus to decrease suddenly. The degree and extent of symptoms depend on the size and location of the obstruction , the occurrence of clot fragmentation with embolism to smaller vessels, and the degree of peripheral arterial disease (PAD). Traumatic injury to an extremity may produce partial or total occlusion of
Eicosanoid - Misplaced Pages Continue
2336-406: The essential fatty acids . In 1935, von Euler identified prostaglandin. In 1964, Bergström and Samuelsson linked these observations when they showed that the "classical" eicosanoids were derived from arachidonic acid, which had earlier been considered to be one of the essential fatty acids. In 1971, Vane showed that aspirin and similar drugs inhibit prostaglandin synthesis. Von Euler received
2409-523: The large intestine (colon) is called ischemic colitis . Ischemia of the small bowel is called mesenteric ischemia . Brain ischemia is insufficient blood flow to the brain , and can be acute or chronic . Acute ischemic stroke is a neurological emergency typically caused by a blood clot blocking blood flow in a vessel in the brain. Chronic ischemia of the brain may result in a form of dementia called vascular dementia . A sudden, brief episode (symptoms lasting only minutes) of ischemia affecting
2482-419: The pathogenesis of atherosclerosis . The oxidation in eicosanoid generation is compartmentalized; this limits the peroxides' damage. The enzymes that are biosynthetic for eicosanoids (e.g., glutathione-S-transferases , epoxide hydrolases , and carrier proteins ) belong to families whose functions are involved largely with cellular detoxification. This suggests that eicosanoid signaling might have evolved from
2555-581: The specialized pro-resolving mediators class of eicosanoids, possess anti-inflammatory and inflammation resolving activity. In a randomized controlled trial , AT-LXA 4 and a comparatively stable analog of LXB 4 , 15 R/S -methyl-LXB 4 , reduced the severity of eczema in a study of 60 infants and, in another study, inhaled LXA 4 decreased LTC 4 -initiated bronchoprovocation in patients with asthma. The eoxins (EXC 4 , EXD 4 , EXE 5 ) are newly described. They stimulate vascular permeability in an ex vivo human vascular endothelial model system, and in
2628-451: The thromboxane receptors , G-protein-coupled receptors coupled to the G protein G q . Thromboxane is a vasoconstrictor and a potent hypertensive agent, and it facilitates platelet aggregation. It is in homeostatic balance in the circulatory system with prostacyclin , a related compound. The mechanism of secretion of thromboxanes from platelets is still unclear. They act in the formation of blood clots and reduce blood flow to
2701-462: The 5-series LTs (e.g. LTB 5 , LTC 5 , LTD 5 , and LTE 5 ). Many of the 3-series prostanoids, the hydroxyeicosapentaenoic acids, and the 5-series LT have been shown or thought to be weaker stimulators of their target cells and tissues than their arachidonic acid-derived analogs. They are proposed to reduce the actions of their arachidonate-derived analogs by replacing their production with weaker analogs. Eicosapentaenoic acid-derived counterparts of
2774-406: The E series resolvins (RvEs) (see Specialized pro-resolving mediators ). When this occurs with enzymes located in different cell types and involves the transfer of one enzyme's product to a cell which uses the second enzyme to make the final product it is referred to as transcellular metabolism or transcellular biosynthesis. The oxidation of lipids is hazardous to cells, particularly when close to
2847-475: The aerobic metabolic rate of the affected cells, reducing the immediate effects of hypoxia . Reduction of body temperature also reduces the inflammation response and reperfusion injury. For frostbite injuries, limiting thawing and warming of tissues until warmer temperatures can be sustained may reduce reperfusion injury . Ischemic stroke is at times treated with various levels of statin therapy at hospital discharge, followed by home time, in an attempt to lower
2920-460: The arachidonic acid cascade. EPA (20:5 ω−3) provides the most important competing cascade. DGLA (20:3 ω−6) provides a third, less prominent cascade. These two parallel cascades soften the inflammatory effects of AA and its products. Low dietary intake of these less-inflammatory fatty acids, especially the ω−3s, has been linked to several inflammation-related diseases, and perhaps some mental illnesses . The U.S. National Institutes of Health and
2993-442: The beneficial effects of greater ω-3 intake. Arachidonic acid (AA; 20:4 ω−6) sits at the head of the "arachidonic acid cascade" – more than twenty eicosanoid-mediated signaling paths controlling a wide array of cellular functions, especially those regulating inflammation , immunity, and the central nervous system . In the inflammatory response, two other groups of dietary fatty acids form cascades that parallel and compete with
Eicosanoid - Misplaced Pages Continue
3066-666: The body, causing a shortage of oxygen that is needed for cellular metabolism (to keep tissue alive). Ischemia is generally caused by problems with blood vessels , with resultant damage to or dysfunction of tissue i.e. hypoxia and microvascular dysfunction . It also implies local hypoxia in a part of a body resulting from constriction (such as vasoconstriction , thrombosis , or embolism ). Ischemia causes not only insufficiency of oxygen, but also reduced availability of nutrients and inadequate removal of metabolic wastes . Ischemia can be partial (poor perfusion ) or total blockage. The inadequate delivery of oxygenated blood to
3139-422: The brain is called a transient ischemic attack (TIA), often called a mini-stroke. TIAs can be a warning of future strokes, with approximately 1/3 of TIA patients having a serious stroke within one year. Inadequate blood supply to a limb may result in acute limb ischemia or chronic limb threatening ischemia . Reduced blood flow to the skin layers may result in mottling or uneven, patchy discoloration of
3212-592: The classic inflammatory response. Short acting vasoconstrictors — TXA 2 — are released quickly after the injury. The site may momentarily turn pale. Then TXA 2 mediates the release of the vasodilators PGE 2 and LTB 4 . The blood vessels engorge and the injury reddens. Swelling —LTB 4 makes the blood vessels more permeable. Plasma leaks out into the connective tissues, and they swell. The process also loses pro-inflammatory cytokines. Pain —The cytokines increase COX-2 activity. This elevates levels of PGE 2 , sensitizing pain neurons. Heat —PGE 2
3285-586: The clinical significance of eoxins has not yet been demonstrated. RvE1, 18S-RvE1, RvE2, and RvE3, like other members of the specialized pro-resolving mediators) class of eicosanoids, possess anti-inflammatory and inflammation resolving activity. A synthetic analog of RvE1 is in clinical phase III testing (see Phases of clinical research ) for the treatment of the inflammation-based dry eye syndrome ; along with this study, other clinical trials (NCT01639846, NCT01675570, NCT00799552 and NCT02329743) using an RvE1 analogue to treat various ocular conditions are underway. RvE1
3358-552: The clot over a period of 24 to 48 hours. Direct arteriotomy may be necessary to remove the clot. Surgical revascularization may be used in the setting of trauma (e.g., laceration of the artery). Amputation is reserved for cases where limb salvage is not possible. If the patient continues to have a risk of further embolization from some persistent source, such as chronic atrial fibrillation , treatment includes long-term oral anticoagulation to prevent further acute arterial ischemic episodes. Decrease in body temperature reduces
3431-443: The deleterious consequences associated with the consumption of ω−6 PUFA-rich diets reflects excessive production and activities of ω−6 PUFA-derived eicosanoids, while the beneficial effects associated with the consumption of ω−3 PUFA-rich diets reflect the excessive production and activities of ω−3 PUFA-derived eicosanoids. In this view, the opposing effects of ω−6 PUFA-derived and ω−3 PUFA-derived eicosanoids on key target cells underlie
3504-540: The detoxification of ROS. The cell must realize some benefit from generating lipid hydroperoxides close-by its nucleus. PGs and LTs may signal or regulate DNA transcription there; LTB 4 is ligand for PPARα . (See diagram at PPAR .) Both COX1 and COX2 (also termed prostaglandin-endoperoxide synthase-1 ( PTGS1 ) and PTGS2 , respectively) metabolize arachidonic acid by adding molecular O 2 between carbons 9 and 11 to form an endoperoxide bridge between these two carbons, adding molecular O 2 to carbon 15 to yield
3577-521: The detrimental and beneficial effects of ω−6 and ω−3 PUFA-rich diets on inflammation and allergy reactions, atherosclerosis , hypertension , cancer growth, and a host of other processes. "Eicosanoid" (from Greek eicosa- 'twenty') is the collective term for straight-chain PUFAs ( polyunsaturated fatty acids ) of 20 carbon units in length that have been metabolized or otherwise converted to oxygen-containing products. The PUFA precursors to
3650-513: The eicosanoids include: A particular eicosanoid is denoted by a four-character abbreviation, composed of: The stereochemistry of the eicosanoid products formed may differ among the pathways. For prostaglandins, this is often indicated by Greek letters (e.g. PGF 2α versus PGF 2β ). For hydroperoxy and hydroxy eicosanoids an S or R designates the chirality of their substituents (e.g. 5 S -hydroxy-eicosateteraenoic acid [also termed 5( S )-, 5S-hydroxy-, and 5(S)-hydroxy-eicosatetraenoic acid]
3723-426: The eoxins have not been described. The epoxy eicosatrienoic acids (or EETs)—and, presumably, the epoxy eicosatetraenoic acids—have vasodilating actions on heart , kidney , and other blood vessels as well as on the kidney's reabsorption of sodium and water, and act to reduce blood pressure and ischemic and other injuries to the heart, brain , and other tissues ; they may also act to reduce inflammation, promote
SECTION 50
#17330924413233796-488: The glutamate and glycine residues of LTC 4 are removed step-wise by gamma-glutamyltransferase and a dipeptidase to form sequentially LTD 4 and LTE 4 . The decision to form LTB 4 versus LTC 4 depends on the relative content of LTA 4 hydrolase versus LTC 4 synthase (or glutathione S-transferase in cells; eosinophils , mast cells , and alveolar macrophages possess relatively high levels of LTC 4 synthase and accordingly form LTC 4 rather than or to
3869-476: The growth and metastasis of certain tumors , promote the growth of new blood vessels, in the central nervous system , regulate the release of neuropeptide hormones , and in the peripheral nervous system inhibit or reduce pain perception. The reduction in AA-derived eicosanoids and the diminished activity of the alternative products generated from ω-3 fatty acids serve as the foundation for explaining some of
3942-460: The heart muscle, or myocardium , receives insufficient blood flow. This most frequently results from atherosclerosis , which is the long-term accumulation of cholesterol-rich plaques in the coronary arteries . In most Western countries, Ischemic heart disease is the most common cause of death in both men and women, and a major cause of hospital admissions. Both large and small intestines can be affected by ischemia. The blockage of blood flow to
4015-466: The inducible COX-2 isoforms is the hallmark of NSAIDs (non-steroidal anti-inflammatory drugs), such as aspirin . Prostanoids also activate the PPAR γ members of the steroid/thyroid family of nuclear hormone receptors , and directly influence gene transcription . Prostanoids have numerous other relevancies to clinical medicine as evidence by their use, the use of their more stable pharmacological analogs, of
4088-429: The influence on eicosanoids, dietary polyunsaturated fats modulate immune response through three other molecular mechanisms. They (a) alter membrane composition and function , including the composition of lipid rafts ; (b) change cytokine biosynthesis; and (c) directly activate gene transcription. Of these, the action on eicosanoids is the best explored Recent data in 2024 has emerged that neuronal integrity breakdown
4161-412: The initiation of the catalysis of fatty acids to eicosanoids: Two different enzymes may act in series on a PUFA to form more complex metabolites. For example, ALOX5 acts with ALOX12 or aspirin-treated COX-2 to metabolize arachidonic acid to lipoxins and with cytochrome P450 monooxygenase(s), bacterial cytochrome P450 (in infected tissues), or aspirin-treated COX2 to metabolize eicosapentaenoic acid to
4234-968: The lung tissue of asthmatic subjects exposed to specific allergens. They play a pathophysiological role in diverse types of immediate hypersensitivity reactions. Drugs that block their activation of the CYSLTR1 receptor viz., montelukast , zafirlukast , and pranlukast , are used clinically as maintenance treatment for allergen-induced asthma and rhinitis ; nonsteroidal anti-inflammatory drug -induced asthma and rhinitis (see aspirin-exacerbated respiratory disease ); exercise- and cold-air induced asthma (see Exercise-induced bronchoconstriction ); and childhood sleep apnea due to adenotonsillar hypertrophy (see Acquired non-inflammatory myopathy § Diet and Trauma Induced Myopathy ). When combined with antihistamine drug therapy, they also appear useful for treating urticarial diseases such as hives. LxA 4 , LxB 4 , 15-epi-LxA 4 , and 15-epi-LXB 4 , like other members of
4307-559: The lysophospholipid that becomes platelet-activating factor . Next, the free fatty acid is oxygenated along any of several pathways; see the Pathways table. The eicosanoid pathways ( via lipoxygenase or COX ) add molecular oxygen (O 2 ). Although the fatty acid is symmetric , the resulting eicosanoids are chiral ; the oxidations proceed with high stereoselectivity (enzymatic oxidations are considered practically stereospecific ). Four families of enzymes initiate or contribute to
4380-425: The metabolism of dihomo-gamma-linolenic acid to prostanoids and mead acid to 5(S)-hydroxy-6E,8Z,11Z-eicosatrienoic acid (5-HETrE), 5-oxo-6,8,11-eicosatrienoic acid (5-oxo-ETrE), LTA 3 , and LTC 3 involve the same enzymatic pathways that make their arachidonic acid-derived analogs. Eicosanoids typically are not stored within cells but rather synthesized as required. They derive from the fatty acids that make up
4453-528: The non-classic epoxyeicosatrienoic acids (EETs) by converting one of the fatty acid's double bonds to its epoxide to form one or more of the following EETs, 14,15-ETE, 11,12-EET, 8,9-ETE, and 4,5-ETE. 14,15-EET and 11,12-EET are the major EETs produced by mammalian, including human, tissues. The same CYPs but also CYP4A1, CYP4F8, and CYP4F12 metabolize eicosapentaenoic acid to five epoxide epoxyeicosatetraenoic acids (EEQs) viz., 17,18-EEQ, 14,15-EEQ, 11,12-EEQ. 8,9-EEQ, and 5,6-EEQ. The following table lists
SECTION 60
#17330924413234526-605: The nucleus. There are elaborate mechanisms to prevent unwanted oxidation. COX, the lipoxygenases, and the phospholipases are tightly controlled—there are at least eight proteins activated to coordinate generation of leukotrienes. Several of these exist in multiple isoforms . Oxidation by either COX or lipoxygenase releases reactive oxygen species (ROS) and the initial products in eicosanoid generation are themselves highly reactive peroxides . LTA 4 can form adducts with tissue DNA . Other reactions of lipoxygenases generate cellular damage; murine models implicate 15-lipoxygenase in
4599-406: The organs must be resolved either by treating the cause of the inadequate delivery or reducing the oxygen demand of the system that needs it. For example, patients with myocardial ischemia have a decreased blood flow to the heart and are prescribed with medications that reduce chronotropic and inotropic effect to meet the new level of blood delivery supplied by the stenosed vasculature so that it
4672-556: The site of a clot. If the cap of a vulnerable plaque erodes or ruptures, as in myocardial infarction , platelets stick to the damaged lining of the vessel and to each other within seconds and form a plug. These "Sticky platelets" secrete several chemicals, including thromboxane A2 that stimulate vasoconstriction, reducing blood flow at the site. Thromboxane A 2 (TXA 2 ), produced by activated platelets, has prothrombotic properties, stimulating activation of new platelets as well as increasing platelet aggregation. Platelet aggregation
4745-426: The sited products that have three rather than two double bonds and therefore contain the number 3 in place of 2 attached to their names (e.g. PGE 3 instead of PGE 2 ). The PGE 2 , PGE 1 , and PGD 2 products formed in the pathways just cited can undergo a spontaneous dehydration reaction to form PGA 2 , PGA 1 , and PGJ 2 , respectively; PGJ 2 may then undergo a spontaneous isomerization followed by
4818-409: The skin. Kidney ischemia is a loss of blood flow to the kidney cells. Several physical symptoms include shrinkage of one or both kidneys, renovascular hypertension , acute renal failure , progressive azotemia, and acute pulmonary edema . It is a disease with high mortality rate and high morbidity. Failure to treat could cause chronic kidney disease and a need for renal surgery. Ischemia
4891-927: The specialized pro-resolving mediators. As indicated in their individual Misplaced Pages pages, 5-hydroxyeicosatetraenoic acid (which, like 5-oxo-eicosatetraenoic acid, acts through the OXER1 receptor), 5-oxo-eicosatetraenoic acid , 12-hydroxyeicosatetraenoic acid , 15-hydroxyeicosatetraenoic acid , and 20-hydroxyeicosatetraenoic acid show numerous activities in animal and human cells as well as in animal models that are related to, for example, inflammation, allergic reactions, cancer cell growth, blood flow to tissues, and/or blood pressure. However, their function and relevancy to human physiology and pathology have not as yet been shown. The three cysteinyl leukotrienes, LTC 4 , LTD 4 , and LTE 4 , are potent bronchoconstrictors, increasers of vascular permeability in postcapillary venules , and stimulators of mucus secretion that are released from
4964-424: The synthesis they inhibit: The inhibitors of the target effects of thromboxane are the thromboxane receptor antagonist , including terutroban . Picotamide has activity both as a thromboxane synthase inhibitor and as a thromboxane receptor antagonist. Ridogrel is another example. Ischemia Ischemia or ischaemia is a restriction in blood supply to any tissue , muscle group , or organ of
5037-499: The tissues, causing a greater production of free radicals and reactive oxygen species that damage cells. It also brings more calcium ions to the tissues causing further calcium overloading and can result in potentially fatal cardiac arrhythmias and also accelerates cellular self-destruction . The restored blood flow also exaggerates the inflammation response of damaged tissues, causing white blood cells to destroy damaged cells that may otherwise still be viable. Early treatment
5110-464: The use of their receptor antagonists as indicated in the following chart. PGA 1 , PGA 2 , PGJ 2 , Δ12-PGJ 2 , and 15-deox-Δ12,14-PGJ 2 exhibit a wide range of anti-inflammatory and inflammation-resolving actions in diverse animal models. They therefore appear to function in a manner similar to specialized pro-resolving mediators although one of their mechanisms of action, forming covalent bonds with key signaling proteins, differs from those of
5183-455: The ω−3 and −6 synthesis chains, along with the major eicosanoids from AA, EPA, and DGLA. Dietary ω−3 and GLA counter the inflammatory effects of AA's eicosanoids in three ways, along the eicosanoid pathways: Since antiquity , the cardinal signs of inflammation have been known as: calor (warmth), dolor (pain), tumor (swelling), and rubor (redness). The eicosanoids are involved with each of these signs. Redness —An insect's sting will trigger
5256-475: The ω−9 PUFA mead acid. This subfamily distinction is important. Mammals, including humans, are unable to convert ω−6 into ω−3 PUFA. In consequence, tissue levels of the ω−6 and ω−3 PUFAs and their corresponding eicosanoid metabolites link directly to the amount of dietary ω−6 versus ω−3 PUFAs consumed. Since certain of the ω−6 and ω−3 PUFA series of metabolites have almost diametrically opposing physiological and pathological activities, it has often been suggested that
5329-478: Was reduced by ω−3 treatment in APOE*E4 carriers, suggesting that this treatment may be beneficial for this specific group suggested fish oil supplements might help older adults fight Alzheimer’s disease . In general, the eicosanoids derived from AA promote inflammation, and those from EPA and from GLA ( via DGLA) are less inflammatory, or inactive, or even anti-inflammatory and pro-resolving . The figure shows
#322677